Title |
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms / Simone Thomas, Martin Wermke, Vladan Vučinić, Eva Wagner-Drouet, Andreas Mackensen, Robert Zeiser, Gesine Bug, Michael Schmitt, Wolfgang Herr, Petra U. Prinz, Maja Bürdek, Silke Raffegerst, Anna Tafuri, Christiane Geiger, Kirsty Crame, René Goedkoop, Kai Pinkernell, Dolores J. Schendel ; Herausgeber: Jonas Cicenas |
|---|---|
Involved |
Simone Thomas (Verfasser)
Martin Wermke (Verfasser) Vladan Vučinić (Verfasser) Eva Wagner-Drouet (Verfasser)
Andreas Mackensen (Verfasser)
Robert Zeiser (Verfasser) Gesine Bug (Verfasser) Michael Schmitt (Verfasser) Wolfgang Herr (Verfasser) Petra U. Prinz (Verfasser) Maja Bürdek (Verfasser) Silke Raffegerst (Verfasser) Anna Tafuri (Verfasser) Christiane Geiger (Verfasser) Kirsty Crame (Verfasser) René Goedkoop (Verfasser) Kai Pinkernell (Verfasser) Dolores J. Schendel (Verfasser) Jonas Cicenas (Herausgeber) |
Published |
Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
Subject |
T cell receptor
TCR-T therapy PRAME phase I clinical trial
hematological malignancies
AML MDS MM |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2510100507023.672791278826 (URN) |
Further information |
In: Cancers 17.18 (2025). DOI:10.3390/cancers17182968 |
Record ID |
137865014X |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: